FDA Inspection 1068983 — Metrowest Medical Center-Framingham Campus
The FDA completed an inspection of Metrowest Medical Center-Framingham Campus on Sep 26, 2018 in Framingham, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 26, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Framingham, MA (United States)